Pharmaceutical

Key Narmafotinib Patent Granted in the U.S.

Highlights The Company has received a Certificate of Grant from the US Patent and Trademark Office for a key patent…

3 weeks ago

Waterdrop Inc. Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Dec. 3, 2025 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated…

3 weeks ago

Bioz Stars Awards 2025: Honoring Global Leaders Driving the Future of Scientific Innovation

PALO ALTO, CALIFORNIA / ACCESS Newswire / December 3, 2025 / Bioz, Inc., the world's leading AI-powered platform for scientific…

3 weeks ago

President Trump Fixing DEA Marijuana Policy: Defies Logic, Law, and Science, Says MMJ International Holdings

MMJ International Holdings Exposes the Impossible Federal Catch-22 Blocking FDA Regulated Cannabis Medicine. "This is an equation with no solution.…

3 weeks ago

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

FDA scientific advice meeting provides guidance on planned Phase 3 study of radiodiagnostic lead candidate in treatment-resistant hypertension / primary…

3 weeks ago

Electronic Caregiver Positions Addison Care as a Transformative Enablement Platform for CMS’s New ACCESS Model

LAS CRUCES, NEW MEXICO / ACCESS Newswire / December 2, 2025 / Following CMS's announcement of the new ACCESS Model…

3 weeks ago

President Trump’s Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution

A Geopolitical, Legal, and Public-Health Crisis-and Why MMJ International Holdings Offers a Viable Federal Solution"President Trump is facing an impossible…

3 weeks ago

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on…

3 weeks ago